These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23965736)

  • 1. Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis.
    Hourdequin KC; Schpero WL; McKenna DR; Piazik BL; Larson RJ
    Ann Oncol; 2013 Dec; 24(12):2952-62. PubMed ID: 23965736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
    Miyahara T; Mochinaga S; Kimura S; Aragane N; Yakabe T; Morita S; Okudaira K; Fujito H
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):175-82. PubMed ID: 23064956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
    Griggs JJ; Mangu PB; Anderson H; Balaban EP; Dignam JJ; Hryniuk WM; Morrison VA; Pini TM; Runowicz CD; Rosner GL; Shayne M; Sparreboom A; Sucheston LE; Lyman GH;
    J Clin Oncol; 2012 May; 30(13):1553-61. PubMed ID: 22473167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
    Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
    JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation.
    Shultes KC; Arp C; Stockerl-Goldstein K; Trinkaus K; DeFrates S
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):687-693. PubMed ID: 29225163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
    Wenzell CM; Gallagher EM; Earl M; Yeh JY; Kusick KN; Advani AS; Kalaycio ME; Mukherjee S; Tiu RV; Maciejewski JP; Sekeres MA
    Am J Hematol; 2013 Oct; 88(10):906-9. PubMed ID: 23828018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).
    Morrison VA; McCall L; Muss HB; Jatoi A; Cohen HJ; Cirrincione CT; Ligibel JA; Lafky JM; Hurria A
    J Geriatr Oncol; 2018 May; 9(3):228-234. PubMed ID: 29233548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
    Raman R; Mott SL; Schroeder MC; Phadke S; El Masri J; Thomas A
    Clin Breast Cancer; 2016 Dec; 16(6):480-486. PubMed ID: 27431461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy dosing in overweight and obese patients with cancer.
    Lyman GH; Sparreboom A
    Nat Rev Clin Oncol; 2013 Aug; 10(8):451-9. PubMed ID: 23856744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.
    Jorge AM; Melles RB; Zhang Y; Lu N; Rai SK; Young LH; Costenbader KH; Ramsey-Goldman R; Lim SS; Esdaile JM; Clarke AE; Urowitz MB; Askanase A; Aranow C; Petri M; Choi H
    Arthritis Res Ther; 2018 Jul; 20(1):133. PubMed ID: 29976231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).
    Au-Yeung G; Webb PM; DeFazio A; Fereday S; Bressel M; Mileshkin L
    Gynecol Oncol; 2014 Apr; 133(1):16-22. PubMed ID: 24680586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
    Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
    Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.
    Rosner GL; Hargis JB; Hollis DR; Budman DR; Weiss RB; Henderson IC; Schilsky RL
    J Clin Oncol; 1996 Nov; 14(11):3000-8. PubMed ID: 8918498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J; Bramwell V; Stephenson B
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and effectiveness of carboplatin in obese or overweight patients.
    Grueso Cuesta C; Poquet Jornet JE; Gasent Blesa JM; Valdivia Perez A; Carrera Hueso FJ; Moreno Royo L
    J Oncol Pharm Pract; 2019 Sep; 25(6):1328-1335. PubMed ID: 30086680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
    Schwartz J; Toste B; Dizon DS
    Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative Review.
    Thimotheo Batista JP; Santos Marzano LA; Menezes Silva RA; de Sá Rodrigues KE; Simões E Silva AC
    Curr Med Chem; 2023; 30(9):1003-1028. PubMed ID: 35946096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of initial dofetilide dosing recommendation based on actual body weight in overweight and obese patients.
    Cao DX; Kohatsu A; Eng L; Mei K; Dinh J; Mok I; Moreau N; Le A; Shin J
    J Clin Pharm Ther; 2015 Dec; 40(6):635-9. PubMed ID: 26365492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients.
    Hansen J; Stephan JM; Freesmeier M; Bender D; Button A; Goodheart MJ
    Gynecol Oncol; 2015 Jul; 138(1):154-8. PubMed ID: 25958318
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.